Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...
The conventional wisdom is that there are two important aspects of timing in investing: when to buy a stock and when to sell ...
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...
Eli Lilly is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...
Thanks to the company's ongoing ... So should you buy Eli Lilly stock based on this new finding? If you were on the fence before, take this as a sign that the answer is "yes." ...
Eli Lilly & Co. LLY said Tuesday that patients ... 50% when compared with other incretin medicines for obesity. The drug company said the vials are available through its LillyDirect self-pay ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other Jim Cramer’s best stocks for investors. In a recent episode of Mad Money, Jim Cramer ...